A multi-center randomised controlled trial of gatifloxacin versus azithromycin for the treatment of uncomplicated typhoid fever in children and adults in Vietnam

PLoS ONE

Volumn 3, Issue 5, 2008, Pages

  Dolecek, Christiane ^a,e,f   La, Tran Thi Phi ^c   Rang, Nguyen Ngoc ^c   Phuong, Le Thi ^d   Vinh, Ha ^b   Tuan, Phung Quoc ^a   Du, Doan Cong ^c   Bay, Nguyen Thi Be ^c   Long, Duong Thanh ^c   Ha, Luong Bich ^c   Binh, Nguyen Trung ^c   Hong, Nguyen Thi Anh ^c   Dung, Pham Ngoc ^c   Lanh, Mai Ngoc ^d   Van Be Bay, Phan ^d   Ho, Vo Anh ^d   Van Minh Hoang, Nguyen ^b   Nga, Tran Thu Thi ^a,b   Chau, Tran Thuy ^b   Schultsz, Constance ^a,e   Dunstan, Sarah J ^a,e   Stepniewska, Kasia ^a,e   Campbell, James Ian ^a,e   Diep, To Song ^b   Basnyat, Buddha ^g   Van Vinh Chau, Nguyen ^b   Van Sach, Nguyen ^c   Chinh, Nguyen Tran ^b   Hien, Tran Tinh ^b   Farrar, Jeremy ^a,e,f   more..

^a OXFORD UNIVERSITY CLINICAL RESEARCH UNIT   (Viet Nam)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c An Giang Provincial Hospital   (Viet Nam)

^d Dong Thap Provincial Hospital   (Viet Nam)

^e JOHN RADCLIFFE HOSPITAL   (United Kingdom)

^f LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^g PATAN HOSPITAL   (Nepal)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; CEFTRIAXONE; GATIFLOXACIN; NALIDIXIC ACID; TECQUIN; ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE;

ADOLESCENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BLOOD CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG COST; DRUG EFFICACY; DRUG SAFETY; DRUG SUBSTITUTION; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FECES ANALYSIS; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; MACULOPAPULAR RASH; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MULTIDRUG RESISTANCE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; RANDOMIZED CONTROLLED TRIAL; RECOMMENDED DRUG DOSE; RECURRENCE RISK; RISK ASSESSMENT; SALMONELLA ENTERICA; TREATMENT DURATION; TREATMENT RESPONSE; TYPHOID FEVER; VIET NAM; VOMITING; ADULT; CHILD; CLASSIFICATION; DRUG EFFECT; MICROBIOLOGICAL EXAMINATION; SALMONELLA; SPECIES DIFFERENCE;

SALMONELLA ENTERICA SUBSP. ENTERICA SEROVAR TYPHI; SALMONELLA TYPHI;

ADULT; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHILD; FLUOROQUINOLONES; HUMANS; MICROBIAL SENSITIVITY TESTS; SALMONELLA; SPECIES SPECIFICITY; TYPHOID FEVER;

EID: 48249103525     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0002188     Document Type: Article

References (33)

1. Crump JA, Luby SP, Mintz ED (2004) The global burden of typhoid fever. Bull World Health Organ 82: 346-353.
2. Bhan MK, Bahl R, Bhatnagar S (2005) Typhoid and paratyphoid fever. Lancet 366: 749-762.
3. Bhutta ZA (2006) Current concepts in the diagnosis and treatment of typhoid fever. Bmj 333: 78-82.
4. Parry CM, Hien TT, Dougan G, White NJ, Farrar JJ (2002) Typhoid fever. N Engl J Med 347: 1770-1782.
5. Nguyen TA, Ha Ba K, Nguyen TD (1993) [Typhoid fever in South Vietnam, 1990-1993]. Bull Soc Pathol Exot 86: 476-478.
6. Chau TT, Campbell JI, Galindo CM, Van Minh Hoang N, Diep TS, et al. (2007) Antimicrobial drug resistance of Salmonella enterica serovar Typhi in Asia and molecular mechanism of reduced susceptibility to the fluoroquinolones. Antimicrob Agents Chemother 51: 4315-4323.
7. Chinh NT, Parry CM, Ly NT, Ha HD, Thong MX, et al. (2000) A randomized controlled comparison of azithromycin and ofloxacin for treatment of multidrug-resistant or nalidixic acid-resistant enteric fever. Antimicrob Agents Chemother 44: 1855-1859.
8. Parry CM, Ho VA, Phuong le T, Bay PV, Lanh MN, et al. (2007) Randomized controlled comparison of ofloxacin, azithromycin, and an ofloxacin-azithromycin combination for treatment of multidrug-resistant and nalidixic acid-resistant typhoid fever. Antimicrob Agents Chemother 51: 819-825.
9. WHO (2003) Backgound document: The diagnosis, treatment and prevention of typhoid fever. Department of Vaccines and Biologicals - World Health Organization. http://www.who.int/vaccine_research/documents/en/ typhoid_diagnosis.pdf.
10. Pandit A, Arjyal A, Day JN, Paudyal B, Dangol S, et al. (2007) An open randomized comparison of gatifloxacin versus cefixime for the treatment of uncomplicated enteric fever. PLoS ONE 2: e542.
11. Maskey AP, Day JN, Phung QT, Thwaites GE, Campbell JI, et al. (2006) Salmonella enterica serovar Paratyphi A and S. enterica serovar Typhi cause indistinguishable clinical syndromes in Kathmandu, Nepal. Clin Infect Dis 42: 1247-1253.
12. Clinical and Laboratory Standard Institute (2006) Performance standards for antimicrobial susceptibility tests. Approved standard, 9th ed. CLSI document M2-A9. CLSI, Pennsylvania, USA.
13. Clinical and Laboratory Standard Institute (2007) Performance standards for antimicrobial susceptibility testing; seventeenth informational supplement. MS100-S17. CLSI, Pennsylvania, USA.
14. Machin D, Campbell MJ, Fayers PM, Pinol APY (1997) Sample size tables for the design of clinical trials (2nd edition). Oxford: Blackwell Science.
15. Breslow NE, Day NE (1980) Statistical methods in cancer research. Volume 1 - The analysis of case-control studies. Lyon: International Agency for Research on Cancer.
16. Collett D (2003) Modelling survival data in medical research (2nd edition). Boca Raton: CRC Press.
17. Cao XT, Kneen R, Nguyen TA, Truong DL, White NJ, et al. (1999) A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. The Dong Nai Pediatric Center Typhoid Study Group. Pediatr Infect Dis J 18: 245-248.
18. Tran TH, Bethell DB, Nguyen TT, Wain J, To SD, et al. (1995) Short course of ofloxacin for treatment of multidrug-resistant typhoid. Clin Infect Dis 20: 917-923.
19. Vinh H, Wain J, Vo TN, Cao NN, Mai TC, et al. (1996) Two or three days of ofloxacin treatment for uncomplicated multidrug-resistant typhoid fever in children. Antimicrob Agents Chemother 40: 958-961.
20. Lu T, Zhao X, Drlica K (1999) Gatifloxacin activity against quinolone-resistant gyrase: allele-specific enhancement of bacteriostatic and bactericidal activities by the C-8-methoxy group. Antimicrob Agents Chemother 43: 2969-2974.
21. Tam VH, Louie A, Deziel MR, Liu W, Drusano GL (2007) The relationship between quinolone exposures and resistance amplification is characterized by an inverted U: a new paradigm for optimizing pharmacodynamics to counterselect resistance. Antimicrob. Agents Chemother 51: 744-747.
22. Ambrose PG, Bhavnani SM, Cirincione BB, Piedmonte M, Grasela TH (2003) Gatifloxacin and the elderly: pharmacokinetic-pharmacodynamic rationale for a potential age-related dose reduction. J Antimicrob Chemother 52: 435-440.
23. Baker SE, Hangii MC (2002) Possible gatifloxacin-induced hypoglycemia. Ann Pharmacother 36: 1722-1726.
24. Frothingham R (2005) Glucose homeostasis abnormalities associated with use of gatifloxacin. Clin Infect Dis 41: 1269-1276.
25. Park-Wyllie LY, Juurlink DN, Kopp A, Shah BR, Stukel TA, et al. (2006) Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med 354: 1352-1361.
26. Pichichero ME, Arguedas A, Dagan R, Sher L, Saez-Llorens X, et al. (2005) Safety and efficacy of gatifloxacin therapy for children with recurrent acute otitis media (AOM) and/or AOM treatment failure. Clin Infect Dis 41: 470-478.
27. Aarestrup FM, Wiuff C, Molbak K, Threlfall EJ (2003) Is it time to change fluoroquinolone breakpoints for Salmonella spp.? Antimicrob Agents Chemother 47: 827-829.
28. Kadhiravan T, Wig N, Kapil A, Kabra SK, Renuka K, et al. (2005) Clinical outcomes in typhoid fever: adverse impact of infection with nalidixic acid-resistant Salmonella typhi. BMC Infect Dis 5: 37.
29. Thaver D, Zaidi AK, Critchley J, Madni SA, Bhutta ZA (2005) Fluoroquinolones for treating typhoid and paratyphoid fever (enteric fever). Cochrane Database Syst Rev: CD004530.
30. Frenck RW Jr, Mansour A, Nakhla I, Sultan Y, Putnam S, et al. (2004) Short-course azithromycin for the treatment of uncomplicated typhoid fever in children and adolescents. Clin Infect Dis 38: 951-957.
31. Butler T, Sridhar CB, Daga MK, Pathak K, Pandit RB, et al. (1999) Treatment of typhoid fever with azithromycin versus chloramphenicol in a randomized multicentre trial in India. J Antimicrob Chemother 44: 243-250.
32. Frenck RW Jr, Nakhla I, Sultan Y, Bassily SB, Girgis YF, et al. (2000) Azithromycin versus ceftriaxone for the treatment of uncomplicated typhoid fever in children. Clin Infect Dis 31: 1134-1138.
33. Girgis NI, Butler T, Frenck RW, Sultan Y, Brown FM, et al. (1999) Azithromycin versus ciprofloxacin for treatment of uncomplicated typhoid fever in a randomized trial in Egypt that included patients with multidrug resistance. Antimicrob Agents Chemother 43: 1441-1444.